Literature DB >> 28374631

A narrative review of the impact of medical comorbidities on stroke rehabilitation outcomes.

Alan K H Tam1, Mark T Bayley1.   

Abstract

PURPOSE: Medical comorbidities in stroke patients influence acute mortality, but may also affect participation of survivors in rehabilitation. There is limited research investigating the impact of comorbidities on stroke rehabilitation outcomes. The review will explore the literature on the impact of comorbidities on stroke rehabilitation outcome.
MATERIALS AND METHODS: The literature was searched systematically, including MEDLINE database, EMBASE and PsychINFO, combining variations of the terms stroke, rehabilitation and comorbidities. Results were limited to English language publications. Included studies had a functional outcome.
RESULTS: Twenty relevant articles were identified. Fifteen small prospective or large retrospective studies using global comorbidity scales produced conflicting relationships between comorbidities and rehabilitation outcomes. Five publications addressed specific comorbidities, with three studies finding negative correlation between diabetes and rehabilitation outcomes, although effects diminished with age. In general, there were discrepancies in how comorbidities were identified. Few studies specifically focused on comorbidities and/or rehabilitation outcomes.
CONCLUSIONS: There is conflicting evidence regarding the impact of comorbidities on stroke rehabilitation outcomes. However, the presence of more severe diabetes may be associated with worse outcomes. The role of comorbidities in stroke rehabilitation would be best clarified with a large cohort study, with precise comorbidity identification measured against rehabilitation specific outcomes. Implications for rehabilitation Benefit of rehabilitation after stroke in improving functional outcome is well-established. Many stroke patients have comorbid conditions which can impact rehabilitation participation, leading to less benefit obtained from rehabilitation. The burden of comorbid conditions may slow rehabilitation progress, which may warrant a longer duration of rehabilitation to obtain required functional gain to be discharged into the community.

Entities:  

Keywords:  Stroke; comorbidity; functional outcomes; rehabilitation

Mesh:

Year:  2017        PMID: 28374631     DOI: 10.1080/09638288.2017.1309465

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  5 in total

1.  Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis.

Authors:  Adys Mendizabal; Dylan P Thibault; James A Crispo; Adina Paley; Allison W Willis
Journal:  Neurol Clin Pract       Date:  2020-06

2.  An iPad application-based intervention for improving post-stroke depression symptoms in a convalescent rehabilitation ward: A pilot randomized controlled clinical trial protocol.

Authors:  Hiroyuki Uchida; Yoshiya Hiragaki; Yuta Nishi; Shiori Nakahara; Junki Koumoto; Yusuke Onmyoji; Norimasa Fujimoto; Kazuho Kawakami; Masato Ishii; Kazuki Hirao
Journal:  Internet Interv       Date:  2020-08-27

3.  Prevalence, Patterns, and Predictors of Multimorbidity in Adults With Acquired Brain Injury at Admission to Staged Community-Based Rehabilitation.

Authors:  Hayley M Jackson; Lakkhina Troeung; Angelita Martini
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-10-30

4.  Association Between Sleep Duration and Functional Disability in Inpatient Stroke Rehabilitation: A Pilot Observational Study.

Authors:  Cierra Williams-Cooke; Elise Watts; Jonathan Bonnett; Mohammed Alshehri; Catherine Siengsukon
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-07-26

5.  Evaluation of anticoagulation status for atrial fibrillation on early ischaemic stroke outcomes: a registry-based, prospective cohort study of acute stroke care in Surrey, UK.

Authors:  Thang S Han; Christopher H Fry; David Fluck; Brendan Affley; Giosue Gulli; Christopher Barrett; Puneet Kakar; Tasmin Patel; Sapna Sharma; Pankaj Sharma
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.